Wahlgren M, Carlson J, Helmby H, Hedlund I, Treutiger C J
Department of Infectious Diseases, Karolinska Institutet, Huddinge Hospital, Sweden.
Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:323-9. doi: 10.1590/s0074-02761992000700054.
Rosetting, i.e. the spontaneous binding of uninfected to malaria infected erythrocytes and endothelial cytoadherence may hinder the blood flow and lead to severe Plasmodium falciparum malaria. Falciparum isolates obtained from unconscious patients all form rosettes and/or express a significantly higher mean rosetting rate than isolates from patients with uncomplicated malaria. Furthermore, sera of patients with cerebral malaria are devoid of anti-rosetting activity while sera from patients with mild disease carry high levels of anti-rosetting antibodies. The presence of anti-rosetting antibodies also seems important for the efficient interaction of rosetting infected rbc and leukocytes. Two parasite derived rosetting ligands of Mr 22K and Mr 28K named "rosettins", have been found on the surface of rosetting infected erythrocytes. CD36 has in at least some strains of parasites been found to function as a rosetting receptor on the uninfected erythrocyte. Heparin disrupts rosettes of P. falciparum in vitro and inhibits the sequestration of rosetting cells ex vivo. In conclusion, rosetting seems a crucial factor in the development of cerebral malaria and treatment of patients with anti-rosetting substances might become an effective adjunct in the treatment of severe malaria.
红细胞凝集,即未感染的红细胞与感染疟原虫的红细胞自发结合以及内皮细胞黏附,可能会阻碍血流并导致严重的恶性疟原虫疟疾。从昏迷患者分离得到的恶性疟原虫分离株均会形成红细胞凝集,和/或表现出比非复杂性疟疾患者分离株显著更高的平均红细胞凝集率。此外,脑型疟患者的血清缺乏抗红细胞凝集活性,而轻症患者的血清则携带高水平的抗红细胞凝集抗体。抗红细胞凝集抗体的存在对于红细胞凝集感染的红细胞与白细胞的有效相互作用似乎也很重要。在红细胞凝集感染的红细胞表面发现了两种分子量分别为22K和28K的寄生虫衍生的红细胞凝集配体,称为“红细胞凝集素”。在至少一些疟原虫菌株中,已发现CD36可作为未感染红细胞上的红细胞凝集受体。肝素在体外可破坏恶性疟原虫的红细胞凝集,并在体内抑制红细胞凝集细胞的滞留。总之,红细胞凝集似乎是脑型疟发展的关键因素,用抗红细胞凝集物质治疗患者可能成为重症疟疾治疗的有效辅助手段。